Congenital Ichthyosis: A Practical Clinical Guide on Current Treatments and Future Perspectives

References

• Tontchev G, Silverberg NB, Shlasko E, Henry C, Roberts JL, Roth MZ. Techniques for toddlers: linear band incision for harlequin ichthyosis with associated compartment syndrome. Pediatr Dermatol. 2014;31(5):625–629. PMID: 25187390. doi:10.1111/pde.12446
   PubMed Web of Science ®Google Scholar
• Frascari F, Drefus I, Rodriguez L, et al. Prevalence and risk factors of vitamin D deficiency in inherited ichthyosis: a French prospective observational study performed in a reference center. Orphanet J Rare Dis. 2014;9:127. doi:10.1186/s13023-014-0127-3
   PubMed Web of Science ®Google Scholar
• Milstone LM. Scaly skin and bath pH: rediscovering baking soda. J Am Acad Dermatol. 2010;62(5):885–886. PMID: 20398816. doi:10.1016/j.jaad.2009.04.011
   PubMed Web of Science ®Google Scholar
• Bodemer C, Bourrat E, Mazereeuw-Hautier J, et al. Short- and medium-term efficacy of specific hydrotherapy in inherited ichthyosis. Br J Dermatol. 2011;165(5):1087–1094. PMID: 21729027. doi:10.1111/j.1365-2133.2011.10510.x
   PubMed Web of Science ®Google Scholar
• Kaplan L, Castelo-Soccio L. Topical N-acetylcysteine in ichthyosis: experience in 18 patients. Pediatr Dermatol. 2018;35(4):528–530. PMID: 29582451. doi:10.1111/pde.13489
   PubMed Web of Science ®Google Scholar
• Zaenglein AL, Levy ML, Stefanko NS, et al. Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents. Pediatr Dermatol. 2021;38(1):164–180. doi:10.1111/pde.14408
   PubMed Web of Science ®Google Scholar
• Katugampola RP, Finlay AY. Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years’ experience on 23 patients. Br J Dermatol. 2006;154:267–276. doi:10.1111/j.1365-2133.2005.06906.x
   PubMed Web of Science ®Google Scholar
• DiGiovanna JJ. Isotretinoin effects on bone. J Am Acad Dermatol. 2001;45(5):S176–S182. doi:10.1067/mjd.2001.113721
   PubMed Web of Science ®Google Scholar
• Singh S, Bhura M, Maheshwari A, Kumar A, Singh CP, Pandey SS. Successful treatment of harlequin ichthyosis with Acitretin. Int J Dermatol. 2001;40(7):472–473. PMID: 11679007. doi:10.1046/j.1365-4362.2001.01173.x
   PubMed Web of Science ®Google Scholar
• Haenssle HA, Finkenrath A, Hausser I, et al. Effective treatment of severe thermodysregulation by oral retinoids in a patient with recessive congenital lamellar ichthyosis. Clin Exp Dermatol. 2008;33(5):578–581. PMID: 18355358. doi:10.1111/j.1365-2230.2008.02709.x
   PubMed Web of Science ®Google Scholar
• Craiglow BG, Choate KA, Milstone LM. Topical tazarotene for the treatment of ectropion in ichthyosis. JAMA Dermatol. 2013;149(5):598–600. PMID: 23677086; PMCID: PMC3809825. doi:10.1001/jamadermatol.2013.239
   PubMed Web of Science ®Google Scholar
• Aktas M, Salman A, Apti Sengun O, et al. Netherton syndrome: temporary response to dupilumab. Pediatr Dermatol. 2020;37(6):1210–1211. PMID: 32951242. doi:10.1111/pde.14362
   PubMed Web of Science ®Google Scholar
• Joosten MDW, Clabbers JMK, Jonca N, Mazereeuw-Hautier J, Gostynski AH. New developments in the molecular treatment of ichthyosis: review of the literature. Orphanet J Rare Diseases. 2022;17:269. doi:10.1186/s13023-022-02430-6
   PubMed Web of Science ®Google Scholar
• Paller AS, van Steensel MA, Rodriguez-Martín M, et al. Pathogenesis-based therapy reverses cutaneous abnormalities in an inherited disorder of distal cholesterol metabolism. J Invest Dermatol. 2011;131(11):2242–2248. PMID: 21753784; PMCID: PMC3193573. doi:10.1038/jid.2011.189
   PubMed Web of Science ®Google Scholar
• Kallis P, Bisbee E, Garganta C, Schoch JJ. Rapid improvement of skin lesions in CHILD syndrome with topical 5% simvastatin ointment. Pediatr Dermatol. 2022;39(1):151–152. PMID: 34787337. doi:10.1111/pde.14865
   PubMed Web of Science ®Google Scholar
• Zelieskova M, Banovina P, Kozar M, Kozarova A, Nudzajova Z, Jesenak M. A novel SPINK5 mutation and successful subcutaneous immunoglobulin replacement therapy in a child with Netherton syndrome. Pediatr Dermatol. 2020;37(6):1202–1204. PMID: 32767583. doi:10.1111/pde.14318
   PubMed Web of Science ®Google Scholar
• Lefferdink R, Rangel SM, Chima M, et al. Secukinumab responses vary across the spectrum of congenital ichthyosis in adults. Arch Dermatol Res. 2023;315(2):305–315. PMID: 35218370. doi:10.1007/s00403-022-02325-3
   PubMed Web of Science ®Google Scholar
• Luchsinger I, Knopfel N, Theiler M, et al. Secukinumab therapy for Netherton syndrome. JAMA Dermatol. 2020;156:907–911. doi:10.1001/jamadermatol.2020.1019
   PubMed Web of Science ®Google Scholar
• Steinhoff M, Al-Marri F, Al Chalabi R, Gieler U, Buddenkotte J. Recalcitrant erythrodermic ichthyosis with atopic dermatitis successfully treated with Dupilumab in combination with Guselkumab. Skin Health Dis. 2021;2(1):e87. PMID: 35665208; PMCID: PMC9060106. doi:10.1002/ski2.87
   PubMedGoogle Scholar
• Eytan O, Sarig O, Sprecher E, van Steensel MA. Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14. Br J Dermatol. 2014;171(2):420–422. PMID: 24641799. doi:10.1111/bjd.12952
   PubMed Web of Science ®Google Scholar
• Fuijkschot J, Seyger MM, Bastiaans DE, Wevers RA, Roeleveld N, Willemsen MA. Zileuton for pruritus in Sjögren-Larsson syndrome: a randomized double-blind placebo-controlled crossover trial. Acta Derm Venereol. 2016;96(2):255–256. PMID: 26123322. doi:10.2340/00015555-2195
   PubMed Web of Science ®Google Scholar
• Enjalbert F, Dewan P, Caley MP, et al. 3D model of harlequin ichthyosis reveals inflammatory therapeutic targets. J Clin Invest. 2020;130(9):4798–4810. doi:10.1172/JCI132987
   PubMed Web of Science ®Google Scholar
• Ho M, Nguyen H-N, Hoang MV, et al. Altered skin microbiome, inflammation, and JAK/STAT signaling in Southeast Asian ichthyosis patients. medRxiv. 2022;2022:2022–2008.
   Google Scholar
• Parry TJ, Zhang P, MajumdarA, et al.Preclinical Evaluation of a Modified Herpes Simplex Virus Type 1 Vector Encoding Human TGM1 for the Treatment of Autosomal Recessive Congenital Ichthyosis. J Invest Dermatol. 2021;141(4):874–882.e6. doi:10.1016/j.jid.2020.07.035
   PubMed Web of Science ®Google Scholar
• Di WL, Lwin SM, Petrova A, et al. Generation and clinical application of gene-modified autologous epidermal sheets in Netherton syndrome: lessons learned from a Phase 1 trial. Hum Gene Ther. 2019;30(9):1067–1078. doi:10.1089/hum.2019.049
   PubMed Web of Science ®Google Scholar
• Paller AS, Browning J, Parish LC, Bunick CG, Rome Z, Bhatia N. Safety, tolerability, and efficacy of a novel topical isotretinoin formulation for the treatment of X-linked or lamellar congenital ichthyosis: results from a phase 2a proof-of-concept study. J Am Acad Dermatol. 2022;87(5):1189–1191. PMID: 35271936. doi:10.1016/j.jaad.2022.02.060
   PubMed Web of Science ®Google Scholar
• Teng JMC, Bunick CG, Guenthner S, et al. The CONTROL study: a randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosis. J Am Acad Dermatol. 2022;87(6):1455–1458. PMID: 35872261. doi:10.1016/j.jaad.2022.07.028
   PubMedGoogle Scholar
• Marukian NV, Deng Y, Gan G, et al. Establishing and validating an ichthyosis severity index. J Invest Dermatol. 2017;137(9):1834–1841. PMID: 28596001. doi:10.1016/j.jid.2017.04.037
   PubMed Web of Science ®Google Scholar